A4C News, Newsletter
Rachel Splinter
Change Maker Chronicle: Q3 2026 Edition

The newest Change Maker Chronicle is here! Drug shortages are still impacting patients every day, but together we are pushing forward. See how we’re raising awareness, fostering advocacy, and building resilent drug supply chains to end drug shortages NOW.

Change Maker Chronicle: Q3 2026 Edition
In the News
Rachel Splinter
Cancer drug shortages threaten lives as efforts ...

Drug shortages continue to put patients at risk.

As highlighted by The National Desk’s Spotlight on America, children with cancer and their families continue to face uncertainty when critical medicines like ifosfamide are in short supply.

For Abby Bray, this was personal. Patient One was Abby. Her experience navigating drug shortages during cancer treatment became the catalyst for Laura Bray’s advocacy and the founding of Angels for Change.

We remain committed to advancing solutions that strengthen the pharmaceutical supply chain and ensure every patient has access to the medicines they need.

Cancer drug shortages threaten lives as efforts to prevent them hit regulatory red tape
In the News
Rachel Splinter
Laura Bray featured in the New York Post Amid ...

Women across the country are struggling to access estrogen patches, with some traveling long distances, rationing medication, or searching for alternatives to maintain access to their treatment.

The New York Post recently examined the shortage and the challenges patients are facing. Laura Bray, Founder of Angels for Change, spoke with the publication about why the shortage was predictable following the FDA’s removal of the black box warning for estrogen-based hormone replacement therapy.

Laura Bray featured in the New York Post Amid Estrogen Patch Shortage
Press Release
Rachel Splinter
Angels for Change and Medivant Healthcare ...

Announcing: A new milestone to strengthen U.S. readiness for critical medicines.

Today, Angels for Change and Medivant Healthcare announced the completion of a key Project PROTECT milestone, establishing ready-to-activate U.S. manufacturing capacity for 10% Calcium Chloride Injection, an essential medicine used in emergency and critical care.

Through the partnership, Medivant has completed development of Calcium Chloride Injection and advanced the medicine into Project PROTECT’s readiness phase, creating domestic manufacturing capacity that can be activated when supply disruptions threaten patient access.

“Project PROTECT is about staying ahead of shortages before they reach patients,” said Laura Bray, Chief Change Maker at Angels for Change. “By partnering with Medivant Healthcare to prepare domestic capacity for Calcium Chloride Injection, we are demonstrating what proactive shortage preparedness can look like and building the ability to respond before a supply disruption becomes a patient crisis.”

Since launching in 2022, Project PROTECT has strengthened U.S. readiness for 14 essential medicines, seven of which have subsequently experienced shortages, with more than 850,000 patient treatments accessed during shortages.

Angels for Change and Medivant Healthcare Advance U.S. Readiness for Critical Calcium Chloride Injection
In the News
Rachel Splinter
Patient One, Now a Patient Advocate: Abby Bray ...

For the first time since 2019, Abby Bray is sharing her cancer journey in her own words.

For years, Abby kept her story private. Now, five years cancer-free, she is choosing to share her experience and use her voice to advocate for other patients facing drug shortages.

Abby was Patient One for Angels for Change.

Today, she is helping carry that mission forward as a member of the Angels for Change Patient Advocacy Board, which brings patients, caregivers, and lived experiences directly into our advocacy work.

Patient One, Now a Patient Advocate: Abby Bray Shares Her Story

Angels for Change Goes ALL IN on Ending Drug Shortages with Fifth Annual SummitONE Conference

Angels for Change Goes ALL IN on Ending Drug Shortages with Fifth Annual SummitONE Conference

Angels for Change, a nonprofit organization dedicated to ending drug shortages, hosted the fifth annual SummitONE conference on July 8 and 9 at Fresenius Kabi’s U.S. headquarters in Lake Zurich, Illinois. SummitONE is the only annual conference that gathers supply chain leaders, drug shortage experts, policy makers, and patients to discuss solutions to end drug shortages.

SHARE YOUR “WHY”

Every conversation, partnership, and shared story brings us closer to a future without drug shortages. At Angels for Change, we’re proud to march forth for patients everywhere.

SHARE YOUR STORY